H.E The Chief Executive Officer of SFDA met HE the Ambassador of the Netherlands to the Kingdom, Mr. Ron Striker and the Agricultural counselor Mr. Philip De Young V. to discuss the aspects of mutual cooperation between the two countries and the possible means of strengthening the relationship in the field of control and monitoring food, drug, medical devices & products
SFDA Drug Sector will host the meeting of GCC Animal Resources Managers Standing Committee next week , Sunday & Monday mornings 20 -21/5/1432H (24-25/4/2011) at SFDA Head Office –Drug Sector Building. The meeting will focus on two major points: 1- veterinary medicine practicing regulations and its implementation bylaws & 2- registration of veterinary drugs and products regulations and its implementation bylaws in GCC Countries.
In line with SFDA’s concerns about evaluation of critical drugs, and in view of the cooperation between SFDA Drug Sector and European Medicines Evaluation Agency (EMA), a Two- day workshop was organized to train SFDA Drug Evaluation personnel on evaluation of drugs files
The workshop was opened by H.E. Dr. Mohammed Ahmed Al Kanhal, CEO –SFDA and participated by Dr. Fal Ahmen and Dr. Quid Hue from EMA and addressed three key dimensions covering the quality of drug products, EU & GCC Drug Regulations and other technical and professional issues.
On behalf of HRH Prince Sultan bin Abdul Aziz , Crown Prince, Deputy Premier, Minister of Defense & Aviation, Inspector General and Chairman of SFDA Board of Directors, HRH Prince Dr. Mansur bin Metib bin Abdul Aziz , Minister of Municipal & Rural Affairs Chaired yesterday the 10th. SFDA Board of Directors’ Meeting at the presence of Board Members
HRH Prince Khaled bin Sultan welcomed at his office in Ma’athar, today, H.E Dr. Mohammed bin Ahmed Al Kanhal , CEO of Saudi Food & Drug Authority, SFDA Vice Presidents, Assistants and a number of SFDA staff.
Saudi FDA, represented by Drug Sector, held The 4th. Meeting for f human beings, herbal and veterinary Drug Companies and Agents in Jeddah on 29/5/1432H with the purpose of awareness of all concerned drug importers and manufacturers of the new mechanisms and regulations established by SFDA, upon taking over drug control function, recently.
